{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:29:00Z","timestamp":1780356540701,"version":"3.54.1"},"reference-count":28,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Silesia, School of Medicine in Katowice, Poland","award":["1109\/K\/2\/K"],"award-info":[{"award-number":["1109\/K\/2\/K"]}]},{"name":"Medical University of Silesia, School of Medicine in Katowice, Poland","award":["8211104160"],"award-info":[{"award-number":["8211104160"]}]},{"DOI":"10.13039\/501100005982","name":"Wroclaw University of Science and Technology, Poland","doi-asserted-by":"publisher","award":["1109\/K\/2\/K"],"award-info":[{"award-number":["1109\/K\/2\/K"]}],"id":[{"id":"10.13039\/501100005982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005982","name":"Wroclaw University of Science and Technology, Poland","doi-asserted-by":"publisher","award":["8211104160"],"award-info":[{"award-number":["8211104160"]}],"id":[{"id":"10.13039\/501100005982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Neutrophil gelatinase-associated lipocalin (NGAL) may promote development of inflammation in psoriasis, whereas proprotein convertase subtilisin\/kexin type 9 (PCSK9) may account for dyslipidemia in some psoriatic patients. The aim of the study was to analyze the influence of cyclosporine therapy on serum levels of NGAL and PCSK9 in patients with psoriasis vulgaris. Methods: Serum samples were obtained before and after three months cyclosporine therapy. Patients were grouped into responders and non-responders to cyclosporine depending on whether they achieved at least 50% reduction of Psoriatic Activity Score Index (PASI), or not. Serum levels of PCSK9 and NGAL were assayed using commercially available ELISA tests. Lipid levels were measured with an enzymatic method. Results: There were 40 patients enrolled. A significant decrease in serum NGAL level was seen in cyclosporine responders. No similar dependance was found for PCSK9. Serum PCSK9 concentration correlated with total cholesterol (TChol) and LDL at baseline and after three month treatment. Conclusions: Cyclosporine therapy contributes to the reduction of the NGAL serum but not the PCSK9 concentration. Correlation between the PCSK9 serum level and TChol as well as LDL concentration may help to understand drug induced dyslipidemia after cyclosporine.<\/jats:p>","DOI":"10.3390\/life13091873","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:14:14Z","timestamp":1693995254000},"page":"1873","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin\/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis"],"prefix":"10.3390","volume":"13","author":[{"given":"Aleksandra","family":"Fr\u0105tczak","sequence":"first","affiliation":[{"name":"Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20\/24 Francuska St., 40-067 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-4419","authenticated-orcid":false,"given":"Bartosz","family":"Mizio\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20\/24 Francuska St., 40-067 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5593-5167","authenticated-orcid":false,"given":"Agnieszka","family":"\u0141upicka-S\u0142owik","sequence":"additional","affiliation":[{"name":"Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-5264","authenticated-orcid":false,"given":"Marcin","family":"Sie\u0144czyk","sequence":"additional","affiliation":[{"name":"Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-5427","authenticated-orcid":false,"given":"Karina","family":"Polak","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20\/24 Francuska St., 40-067 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Bergler-Czop","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, 20\/24 Francuska St., 40-067 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jid.2016.03.002","article-title":"Increased Lipocalin-2 Contributes to the Pathogenesis of Psoriasis by Modulating Neutrophil Chemotaxis and Cytokine Secretion","volume":"136","author":"Shao","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/1346-8138.13227","article-title":"Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response","volume":"43","author":"Hau","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5114\/ada.2022.118919","article-title":"The role of proprotein convertase subtilisin\/kexin type 9 (PCSK9) in the pathophysiology of psoriasis and systemic lupus erythematosus","volume":"39","author":"Polak","year":"2022","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jid.2018.07.046","article-title":"Potentiation of Psoriasis-Like Inflammation by PCSK9","volume":"139","author":"Luan","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e141193","DOI":"10.1172\/jci.insight.141193","article-title":"Proprotein convertase subtilisin\/kexin type 9 is a psoriasis-susceptibility locus that is negatively related to IL36G","volume":"7","author":"Merleev","year":"2022","journal-title":"JCI Insight"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00403-013-1414-x","article-title":"Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome","volume":"306","author":"Samir","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","article-title":"Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation","volume":"28","author":"Moschen","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2147\/JIR.S358492","article-title":"Lipocalin 2 Participates in the Epidermal Differentiation and Inflammatory Processes of Psoriasis","volume":"15","author":"Ren","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.jaci.2018.11.042","article-title":"Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab","volume":"143","author":"Visvanathan","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/09546634.2019.1605141","article-title":"Tissue lipocalin-2 in psoriasis: Is it a marker of metabolic disturbance or a possible marker of therapeutic efficacy after narrow band ultraviolet B?","volume":"31","author":"Hay","year":"2020","journal-title":"J. Dermatol. Treat"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Krahel, J.A., Baran, A., Kami\u0144ski, T.W., Maciaszek, M., and Flisiak, I. (2020). Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040910"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3109\/00498254.2010.517276","article-title":"Cyclosporine-induced changes in drug metabolizing enzymes in hyperlipemic rabbit kidneys could explain its toxicity","volume":"40","author":"Elbarbry","year":"2010","journal-title":"Xenobiotica"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.tp.0000188177.21406.97","article-title":"Dietary phytosterols reduce cyclosporine-induced hypercholesterolemia in apolipoprotein E-knockout mice","volume":"81","author":"Moghadasian","year":"2006","journal-title":"Transplantation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/ATVBAHA.115.307030","article-title":"Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia","volume":"36","author":"Kockx","year":"2016","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/hep.510250433","article-title":"Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors","volume":"25","author":"Wallmark","year":"1997","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jid.2020.05.115","article-title":"Characterization of PCSK9 in the Blood and Skin of Psoriasis","volume":"141","author":"Garshick","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1034\/j.1600-0625.2002.110611.x","article-title":"Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin","volume":"11","author":"Mallbris","year":"2002","journal-title":"Exp. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jdermsci.2017.12.018","article-title":"Increased levels of lipocalin 2 in palmoplantar pustular psoriasis","volume":"90","author":"Wolk","year":"2018","journal-title":"Dermatol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.4081\/dr.2022.9469","article-title":"Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis","volume":"14","author":"Nguyen","year":"2022","journal-title":"Dermatol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00403-012-1306-5","article-title":"Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI","volume":"305","author":"Carrascosa","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2230.2011.04265.x","article-title":"Serum lipocalin-2 levels are increased in patients with psoriasis","volume":"37","author":"Kamata","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/09546634.2016.1180340","article-title":"Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels","volume":"28","author":"Baran","year":"2017","journal-title":"J. Dermatol. Treat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/pedi.12490","article-title":"Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women","volume":"18","author":"Levenson","year":"2017","journal-title":"Pediatr. Diabetes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"541709","DOI":"10.1155\/2014\/541709","article-title":"Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis","volume":"2014","author":"Ataseven","year":"2014","journal-title":"Dis. Markers"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2008-1062746","article-title":"Lipocalin-2: Development, analytical characterization, and clinical testing of a new ELISA","volume":"40","author":"Stejskal","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and metabolic syndrome: Implications for the management and treatment of psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/1346-8138.15293","article-title":"Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers","volume":"47","author":"Mazzilli","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"760852","DOI":"10.3389\/fmed.2022.760852","article-title":"The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway","volume":"9","author":"Campione","year":"2022","journal-title":"Front. Med."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/9\/1873\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:45:53Z","timestamp":1760129153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/9\/1873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["life13091873"],"URL":"https:\/\/doi.org\/10.3390\/life13091873","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]}}}